Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Multicenter randomized phase II study of methotrexate (MTX) and temozolomide versus MTX, procarbazine, vincristine and cytarabine for primary CNS [central nervous system] lymphoma (PCNSL) in the elderly.

Trial Profile

Multicenter randomized phase II study of methotrexate (MTX) and temozolomide versus MTX, procarbazine, vincristine and cytarabine for primary CNS [central nervous system] lymphoma (PCNSL) in the elderly.

Completed
Phase of Trial: Phase II

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs Methotrexate (Primary) ; Temozolomide (Primary) ; Cytarabine; Procarbazine; Vincristine
  • Indications Lymphoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 17 Aug 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top